Pinokalant
Product Specifications
CAS Number
149759-26-2
Target
SARS-CoV, TRP/TRPV Channel
Related Pathways
Microbiology/Virology, Membrane transporter/Ion channel
Purity
0.9909
Bioactivity
Pinokalant (LOE-908) is a novel non-selective cation channel inhibitor.Pinokalant significantly reduces cortical infarct volume in in vivo experiments, improves the metabolic and electrophysiological status of the ischemic penumbra region, and reduces the size of the lesion on magnetic resonance images in the acute phase after middle cerebral artery occlusion in rats.Pinokalant is a potential SARS-CoV-2 protease inhibitor for the study of stroke.
Smiles
C(C(N(CCC1=C(OC)C(OC)=C(OC)C=C1)CCC2=C(OC)C(OC)=C(OC)C=C2)=O)(C=3C=4C(=CC(OC)=C(OC)C4)CCN3)C5=CC=CC=C5
Molecular Formula
C41H48N2O9
Molecular Weight
712.83
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUM1505-50 1x 50 µL
CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker) (Ki-1/1505R), 1mg/mL
Sign In for Pricing
View Details 
BNC042672-500 1x 500 µL
CD117 / c-Kit (Marker for Gastrointestinal Stromal Tumors) (KIT/2672), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details